Therefore, these results demonstrate that early treatment of DR with systemic IGF-1 has been shown to reduce apoptotic markers and, subsequently, retinal cell death, even in the setting of persistent hyperglycemia [41]. Here, IGF1 is linked to Hyperglycemia.